FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

24018011000001105: Dapagliflozin 5mg / Metformin 850mg tablets 56 tablet (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 05-Mar 2014. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
78560901000001116 Dapagliflozin 5mg / Metformin 850mg tablets 56 tablet (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
78561001000001113 Dapagliflozin 5mg / Metformin 850mg tablets 56 tablet en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

1 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Dapagliflozin 5mg / Metformin 850mg tablets 56 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Dapagliflozin 5mg / Metformin 850mg tablets 56 tablet Has specific active ingredient Dapagliflozin propanediol monohydrate true Inferred relationship Existential restriction modifier
Dapagliflozin 5mg / Metformin 850mg tablets 56 tablet Is a Virtual medicinal product pack true Inferred relationship Existential restriction modifier
Dapagliflozin 5mg / Metformin 850mg tablets 56 tablet Has VMP Dapagliflozin 5mg / Metformin 850mg tablets true Inferred relationship Existential restriction modifier
Dapagliflozin 5mg / Metformin 850mg tablets 56 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Dapagliflozin 5mg / Metformin 850mg tablets 56 tablet VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Dapagliflozin 5mg / Metformin 850mg tablets 56 tablet Has specific active ingredient Metformin hydrochloride true Inferred relationship Existential restriction modifier
Dapagliflozin 5mg / Metformin 850mg tablets 56 tablet Has specific active ingredient Dapagliflozin false Inferred relationship Existential restriction modifier
Dapagliflozin 5mg / Metformin 850mg tablets 56 tablet Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Dapagliflozin 5mg / Metformin 850mg tablets 56 tablet Has specific active ingredient Dapagliflozin false Inferred relationship Existential restriction modifier
Dapagliflozin 5mg / Metformin 850mg tablets 56 tablet Has specific active ingredient Dapagliflozin propanediol monohydrate false Inferred relationship Existential restriction modifier
Dapagliflozin 5mg / Metformin 850mg tablets 56 tablet Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Dapagliflozin false Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Xigduo 5mg/850mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) 56 tablet 4 x 14 tablets Is a True Dapagliflozin 5mg / Metformin 850mg tablets 56 tablet Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start